Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages

Emerging SARS-CoV-2 sublineages continue to cause serious COVID-19 disease, but most individuals have not received any COVID-19 vaccine for >1 year. Assessment of long-term effectiveness of bivalent COVID-19 vaccines against circulating sublineages is important to inform the potential need for vacci...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Bradley K. Ackerson, Katia J. Bruxvoort, Lei Qian, Lina S. Sy, Sijia Qiu, Julia E. Tubert, Gina S. Lee, Jennifer H. Ku, Ana Florea, Yi Luo, Radha Bathala, Julie Stern, Soon K. Choi, Harpreet S. Takhar, Michael Aragones, Morgan A. Marks, Evan J. Anderson, Cindy Ke Zhou, Tianyu Sun, Carla A. Talarico, Hung Fu Tseng
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2024-12-01
Colecção:	Human Vaccines & Immunotherapeutics
Assuntos:	Bivalent XBB BA.4/BA.5 BA.4 BA.5 omicron
Acesso em linha:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2335052
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!